Piper Sandler Reiterates Overweight on Glaukos, Maintains $165 Price Target
Piper Sandler analyst Adam Maeder reiterates Glaukos (NYSE: GKOS ) with a Overweight and maintains $165 price target.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.